MedPath

SOLU-MEDROL

SOLU-MEDROL (methylprednisolone sodium succinate for injection, USP)

Approved
Approval ID

4cc6480c-df7d-0a78-e054-00144ff88e88

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 9, 2017

Manufacturers
FDA

Sina Health Inc

DUNS: 047161553

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

methylprednisolone sodium succinate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70385-2016
Application NumberNDA011856
Product Classification
M
Marketing Category
C73594
G
Generic Name
methylprednisolone sodium succinate
Product Specifications
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateApril 9, 2017
FDA Product Classification

INGREDIENTS (3)

SODIUM PHOSPHATE, DIBASICInactive
Quantity: 17.4 mg in 1 mL
Code: GR686LBA74
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSInactive
Quantity: 1.6 mg in 1 mL
Code: KH7I04HPUU
Classification: IACT
METHYLPREDNISOLONE SODIUM SUCCINATEActive
Quantity: 125 mg in 1 mL
Code: LEC9GKY20K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SOLU-MEDROL - FDA Drug Approval Details